Kitchener company selling Origin, an FDA-cleared surgical-drain sensor, and Stream Care, machine-learning software that combines sensor and EHR data to flag postoperative complication risk after GI surgery.
Kitchener company selling Origin, an FDA-cleared surgical-drain sensor, and Stream Care, machine-learning software that combines sensor and EHR data to flag postoperative complication risk after GI surgery.
Federal corporation NERV TECHNOLOGY INC. (BN 801509431), status Active, registered office in Kitchener, incorporated 2014-05-29 — now operating as FluidAI Medical. ised-isde.canada.ca ↗
Origin received US FDA 510(k) clearance as a Class 2 device on October 2, 2025, opening US sales for the surgical-drain monitor. fluidai.md ↗
FedDev Ontario invested $2M CAD (July 2025) to help the company scale manufacturing and commercialize Origin and Stream Care. prnewswire.com ↗
Raised a $15M Series A in October 2023 led by SOSV and Graphene Ventures, with Boutique Venture Partners, Threshold Impact, Cur8 Capital, Leva Capital and others. fluidai.md ↗
Works with 50+ global health partners in 4+ countries including Cleveland Clinic and St. Michael's Hospital, per its own site. fluidai.md ↗
Products FluidAI Medical publishes on its own site. Each card links to the page it was taken from.
Origin
Surgical-drain biochemical sensor
A device that attaches to surgical drains and continuously monitors the biochemical composition of drainage fluid to help detect anastomotic leakage early; FDA 510(k)-cleared and Health Canada-cleared.
Combines Origin's sensor data with electronic health record data using machine-learning algorithms to assess postoperative complication risk after gastrointestinal surgery.
AI-powered patient education and engagement platform that monitors patients after hospital discharge, collects outcomes data, and provides personalized education and support, enhanced by the acquired Emmetros SparxConnect technology.
FluidAI acquired Emmetros, developer of the SparxConnect patient engagement platform, to strengthen its Stream Inara post-discharge product within its RISE surgical-journey program.
Origin, FluidAI's inline surgical-drain sensor, received FDA 510(k) clearance as a Class 2 device, allowing US sales of the real-time bedside postoperative monitor.
FluidAI Medical closed a $15M Series A led by SOSV and Graphene Ventures to expand into global markets and grow R&D on its postoperative complication technology.